Wed, Mar 25, 2015 at 2:44 PM
Medical cannabis faces a double standard for safety and efficacy compared to prescription pharmaceuticals.
The most recent illustration of that fact is a story from the Wall Street Journal
, which reported this week that at least a third of children with previously untreatable epilepsy
got better on extracts of cannabis - a non-toxic botanical.
Of 75 children who took cannabidiol (CBD), the second most common active molecule in cannabis, “33% of them had their seizures drop by half,” the Journal
In a study funded by GW Pharmaceuticals — makers of cannabis extract Epidiolex — 40 percent of patients saw seizures decline by more than half and 10 percent became "seizure-free.”
Marijuana — a federally illegal schedule 1 drug with allegedly “no medical use” — temporarily cured one in ten seizure suffers. That sounds like a miracle drug, considering epilepsy is thought to have no cure.
Instead, the Journal
focuses on the kids for whom CBD does not help. In the study of 75 children, 44 percent experienced ‘adverse effects’ sometimes including increased seizures.